Medicare Enrolled
Dr. Pradip Shah, MD
Infectious Disease · Edison, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Pradip Shah is an infectious disease specialist in Edison, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 6,056 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shah received a total of $13,110 from 43 pharmaceutical and/or device companies across 375 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in NJ
$13,110 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,056
Medicare services
Top 8% in NJ for infectious disease
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
2,125 | $103 | $400 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,954 | $68 | $200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
445 | $113 | $300 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
363 | $184 | $600 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
272 | $111 | $300 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
269 | $43 | $100 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
237 | $65 | $150 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
125 | $34 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
71 | $150 | $400 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
68 | $117 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $76 | $200 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
38 | $248 | $450 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $148 | $350 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $183 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$13,110
Total received (2018-2024)
Avg $1,873/year across 7 years
Top 10% in NJ for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
375
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,268
2023
$1,127
2022
$1,692
2021
$1,854
2020
$1,091
2019
$1,258
2018
$820
Payments by company (2024)
Shionogi Inc
$3,802
ViiV Healthcare Company
$348
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$196
Janssen Pharmaceuticals, Inc
$126
GlaxoSmithKline, LLC.
$125
Lexicon Pharmaceuticals, Inc.
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Gilead Sciences, Inc.
$101
Novartis Pharmaceuticals Corporation
$94
Merck Sharp & Dohme LLC
$84
Insmed, Inc.
$80
PFIZER INC.
$44
La Jolla Pharmaceutical Company
$18
Top 3 companies account for 82.5% of 2024 payments
All-time payments by company (2018-2024) ›
Shionogi Inc
$3,802
Gilead Sciences, Inc.
$1,333
ViiV Healthcare Company
$1,116
Boehringer Ingelheim Pharmaceuticals, Inc.
$758
Merck Sharp & Dohme Corporation
$681
Janssen Pharmaceuticals, Inc
$647
Novartis Pharmaceuticals Corporation
$472
Novo Nordisk Inc
$438
Insmed, Inc.
$425
GlaxoSmithKline, LLC.
$375
Janssen Biotech, Inc.
$364
AstraZeneca Pharmaceuticals LP
$250
SANOFI-AVENTIS U.S. LLC
$250
Janssen Products, LP
$249
Lilly USA, LLC
$215
Merck Sharp & Dohme LLC
$203
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$196
E.R. Squibb & Sons, L.L.C.
$125
Kowa Pharmaceuticals America, Inc.
$125
Lexicon Pharmaceuticals, Inc.
$125
COMSORT, Inc
$100
Medtronic MiniMed, Inc.
$83
Abbott Laboratories
$78
Avanir Pharmaceuticals, Inc.
$72
Boston Scientific Corporation
$72
Allergan Inc.
$69
La Jolla Pharmaceutical Company
$64
PFIZER INC.
$60
TETRAPHASE PHARMACEUTICALS, INC.
$50
Teva Pharmaceuticals USA, Inc.
$29
Melinta Therapeutics, LLC
$29
Melinta Therapeutics, Inc.
$29
Nabriva Therapeutics, plc
$27
AbbVie Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$27
Theratechnologies Inc.
$25
Cumberland Pharmaceuticals, Inc.
$25
Sunovion Pharmaceuticals Inc.
$17
ACADIA Pharmaceuticals Inc
$16
VBI Vaccine (Delaware) Inc.
$16
NESTLE HEALTHCARE NUTRITION INC.
$14
Janssen Scientific Affairs, LLC
$14
QOL Medical, LLC
$14
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
APTIOM · AREXVY · AUSTEDO · AVYCAZ · Arikayce · Biktarvy · CABENUVA · CAMZYOS · DIFICID · DOVATO · Descovy · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · Fetroja · INVOKANA · ISENTRESS · Inpefa · JARDIANCE · LEQVIO · MAVYRET · MULTAQ · NUEDEXTA · NUPLAZID · Nuedexta · Orbactiv · Ozempic · PAXLOVID · PIFELTRO · PRALUENT · PREMARIN · PREVYMIS · PREZCOBIX · PREZISTA · PreHevbrio · ROTATEQ · Rybelsus · SUCRAID · SYMTUZA · Seglentis · Supera peripheral stent system · Symtuza · TRELEGY ELLIPTA · TROGARZO · TRULICITY · Truvada · Vabomere · Veklury · Vibativ · WATCHMAN FLX · XACDURO · XARELTO · XERAVA · XIFAXAN · Xenleta · ZENPEP · ZERBAXA · iPro2
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Infectious diseases in nearby ZIP areas
392
County median income
$109,028
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 8% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Shah performed 2,125 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $13,110 from 43 companies across 375 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other infectious diseases in Edison?
Dr. Shah's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Edison
Browse infectious diseases in Edison ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in NJ
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in NJ
Which NJ infectious diseases receive the most from drug and device companies.
By company
Shionogi Inc Payments to Doctors
See all physicians who received payments from Shionogi Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology